Search

Search Constraints

You searched for: Author/Creator Verbeek, Marcel M.

Search Results

2. [O3–10–03]: LONGITUDINAL CEREBROSPINAL FLUID BIOMARKER TRAJECTORIES ALONG THE ALZHEIMER'S DISEASE CONTINUUM: A MULTICENTRE EUROPEAN STUDY. (1st July 2017)

3. [P4–394]: ASSOCIATIONS OF PLASMA AMYLOID BETA LEVELS WITH SEVERITY AND PROGRESSION OF CEREBRAL SMALL VESSEL DISEASE. (1st July 2017)

4. A disbalance of matrix metalloproteinases and their inhibitors in the cerebrospinal fluid from patients with cerebral amyloid angiopathy. (1st February 2022)

5. A disbalance of matrix metalloproteinases and their inhibitors in the cerebrospinal fluid from patients with cerebral amyloid angiopathy. (December 2021)

6. A prediction model to calculate probability of Alzheimer's disease using cerebrospinal fluid biomarkers. Issue 3 (5th November 2012)

7. Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias. Issue 4 (18th November 2013)

8. Amyloid‐βeta peptides in CSF and plasma discriminate cerebral amyloid angiopathy from controls. (1st February 2022)

9. Amyloid‐βeta peptides in CSF and plasma discriminate cerebral amyloid angiopathy from controls. (December 2021)

10. Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositis. Issue 3 (4th March 2013)